Skip to main content
Top
Published in: Clinical Rheumatology 3/2019

01-03-2019 | Original Article

Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls

Authors: Ari Polachek, Inbal Polachek Shlomi, Karen Spitzer, Daniel Pereira, Justine Yang Ye, Vinod Chandran, Carl A. Laskin, Dafna D. Gladman

Published in: Clinical Rheumatology | Issue 3/2019

Login to get access

Abstract

Objectives

The mean age at onset of psoriatic arthritis (PsA) ranges between the 4th–6th decades of life. However, little is known about fertility and pregnancy outcome in PsA patients. The aim of this study was to examine whether fertility and pregnancy outcome of PsA patients are different from healthy controls and to evaluate PsA and psoriasis disease activity perception during pregnancy and the year postpartum.

Methods

A questionnaire-based study, including demographic, fertility, pregnancy outcome, and disease activity questions, was conducted in PsA patients and healthy controls. The inclusion criterion was diagnosis of PsA before at least 1 pregnancy. Descriptive statistics are provided. T tests and Pearson chi-square tests were used to analyze the differences between continuous and categorical variables, respectively.

Results

The 74 PsA patients and 74 healthy controls were not significantly different in most of the demographic variables. The mean number of pregnancies, children, and infertility diagnosis were not significantly different between the groups. The pregnancy outcomes in the PsA group (n = 151) and in the control group (n = 189) were similar in: live birth (76% vs. 76%, P = 0.3), vaginal delivery (48% vs. 51%, P = 0.6), gestation age (38.5 vs. 38.3, P = 0.3), weight at birth (3.4 kg vs. 3.4 kg, P = 0.5), low rate of maternal and fetal complications, and the duration and rate of breastfeeding. Most (58%) patients reported favorable joint activity during pregnancy and 50% reported worsening during the 1st postpartum year.

Conclusions

PsA patients do not have more infertility or worse pregnancy outcomes compared to healthy controls.
Appendix
Available only for authorised users
Literature
1.
go back to reference Helmick CG, Lee-Han H, Hirsch SC, Baird TL, Bartlett CL (2014) Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 National Health and Nutrition Examination Surveys. Am J Prev Med 47:37–45CrossRefPubMedPubMedCentral Helmick CG, Lee-Han H, Hirsch SC, Baird TL, Bartlett CL (2014) Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 National Health and Nutrition Examination Surveys. Am J Prev Med 47:37–45CrossRefPubMedPubMedCentral
2.
go back to reference Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52:568–575CrossRef
3.
go back to reference Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63:1729–1735CrossRef Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63:1729–1735CrossRef
4.
go back to reference Gladman DD, Chandran V (2011) Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 50:25–31CrossRef Gladman DD, Chandran V (2011) Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 50:25–31CrossRef
5.
6.
go back to reference Kammer GM, Soter NA, Gibson DJ, Schur PH (1979) Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9:75–97CrossRefPubMed Kammer GM, Soter NA, Gibson DJ, Schur PH (1979) Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9:75–97CrossRefPubMed
7.
go back to reference Veale D, Rogers S, Fitzgerald O (1994) Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33:133–138CrossRefPubMed Veale D, Rogers S, Fitzgerald O (1994) Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33:133–138CrossRefPubMed
8.
go back to reference Polachek A, Li S, Polachek IS, Chandran V, Gladman D (2017) Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum 46:740–745CrossRefPubMed Polachek A, Li S, Polachek IS, Chandran V, Gladman D (2017) Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum 46:740–745CrossRefPubMed
9.
go back to reference Ostensen M (1992) The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 28:235–237CrossRefPubMed Ostensen M (1992) The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 28:235–237CrossRefPubMed
11.
go back to reference Gladman DD, Thavaneswaran A, Chandran V, Zummer M (2012) Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR). J Rheumatol 39:1850–1853CrossRefPubMed Gladman DD, Thavaneswaran A, Chandran V, Zummer M (2012) Psoriatic arthritis (PsA) in Canadian Clinical Practice: the PsA Assessment in Rheumatology (PAIR). J Rheumatol 39:1850–1853CrossRefPubMed
12.
go back to reference Østensen M (2017) Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol 13:485–493CrossRefPubMed Østensen M (2017) Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol 13:485–493CrossRefPubMed
13.
go back to reference Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg BY, Koldingsnes W, Mikkelsen K, Kaufmann C, Kvien TK (2011) Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 50:1162–1167CrossRef Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg BY, Koldingsnes W, Mikkelsen K, Kaufmann C, Kvien TK (2011) Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 50:1162–1167CrossRef
14.
go back to reference Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K (2012) Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 64:668–674CrossRef Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K (2012) Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 64:668–674CrossRef
15.
go back to reference Ostensen M, Ostensen H (1998) Ankylosing spondylitis-the female aspect. J Rheumatol 25:120–124PubMed Ostensen M, Ostensen H (1998) Ankylosing spondylitis-the female aspect. J Rheumatol 25:120–124PubMed
16.
go back to reference Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg BY, Koldingsnes W, Mikkelsen K, Kaufmannm C, Kvien TK (2011) Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 63:1534–1542CrossRefPubMed Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KÅ, Nordvåg BY, Koldingsnes W, Mikkelsen K, Kaufmannm C, Kvien TK (2011) Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 63:1534–1542CrossRefPubMed
17.
go back to reference Mouyis MA, Thornton CC, Williams D, Giles IP (2017) Pregnancy outcome in patients with psoriatis arthritis. Rheumatol 44:128–129 Mouyis MA, Thornton CC, Williams D, Giles IP (2017) Pregnancy outcome in patients with psoriatis arthritis. Rheumatol 44:128–129
18.
go back to reference Bröms G, Haerskjold A, Granath F, Kieler H, Pedersen L, Berglind IA (2018) Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol 98:728–734CrossRefPubMed Bröms G, Haerskjold A, Granath F, Kieler H, Pedersen L, Berglind IA (2018) Effect of maternal psoriasis on pregnancy and birth outcomes: a population-based cohort study from Denmark and Sweden. Acta Derm Venereol 98:728–734CrossRefPubMed
19.
go back to reference Götestam SC, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795–810CrossRef Götestam SC, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75:795–810CrossRef
20.
go back to reference Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD (2005) Hormonal effect on psoriasis in pregnancy and postpartum. Arch Dermatol 141:601–606CrossRefPubMed Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD (2005) Hormonal effect on psoriasis in pregnancy and postpartum. Arch Dermatol 141:601–606CrossRefPubMed
21.
go back to reference Holland D, Bretscher P, Russell AS (1984) Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol 14:177–179PubMed Holland D, Bretscher P, Russell AS (1984) Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol 14:177–179PubMed
22.
go back to reference Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329:466–471CrossRefPubMed Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329:466–471CrossRefPubMed
23.
go back to reference McHugh NJ, Laurent MR (1989) The effect of pregnancy on the onset of psoriatic arthritis. Br J Rheumatol 28:50–52.23CrossRefPubMed McHugh NJ, Laurent MR (1989) The effect of pregnancy on the onset of psoriatic arthritis. Br J Rheumatol 28:50–52.23CrossRefPubMed
24.
go back to reference Thumboo J, Uramoto K, Shbeeb MI, O'Fallon WM, Crowson CS, Gibson LE et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. Rheumatol 29:757–762 Thumboo J, Uramoto K, Shbeeb MI, O'Fallon WM, Crowson CS, Gibson LE et al (2002) Risk factors for the development of psoriatic arthritis: a population based nested case control study. Rheumatol 29:757–762
25.
go back to reference Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD (2011) Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 63:1091–1097CrossRef Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD (2011) Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 63:1091–1097CrossRef
26.
go back to reference Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67:672–676CrossRefPubMed Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67:672–676CrossRefPubMed
27.
go back to reference Quigley MA, Hockley C, Davidson LL (2007) Agreement between hospital records and maternal recall of mode of delivery: evidence from 12 391 deliveries in the UK Millennium Cohort Study. BJOG 114:195–200CrossRefPubMed Quigley MA, Hockley C, Davidson LL (2007) Agreement between hospital records and maternal recall of mode of delivery: evidence from 12 391 deliveries in the UK Millennium Cohort Study. BJOG 114:195–200CrossRefPubMed
28.
go back to reference Amissah EA, Kancherla V, Ko YA, Li R (2017) Validation study of maternal recall on breastfeeding duration 6 years after childbirth. J Hum Lact 33:390–400CrossRefPubMed Amissah EA, Kancherla V, Ko YA, Li R (2017) Validation study of maternal recall on breastfeeding duration 6 years after childbirth. J Hum Lact 33:390–400CrossRefPubMed
29.
go back to reference Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67CrossRefPubMed Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL (1997) Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol 145:58–67CrossRefPubMed
Metadata
Title
Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls
Authors
Ari Polachek
Inbal Polachek Shlomi
Karen Spitzer
Daniel Pereira
Justine Yang Ye
Vinod Chandran
Carl A. Laskin
Dafna D. Gladman
Publication date
01-03-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4385-7

Other articles of this Issue 3/2019

Clinical Rheumatology 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine